Search for: "Merck & Co. v. TEVA PHARMACEUTICALS USA" Results 1 - 20 of 33
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Sep 2018, 10:17 am by Lawrence B. Ebert
Roxane was that Acorda lost:Roxane Laboratories, Inc.; Mylan Pharmaceuticals,Inc.; and Teva Pharmaceuticals USA, Inc., have submittedAbbreviated New Drug Applications seeking FDAapproval to market generic versions of Ampyra. [read post]
16 Jan 2017, 5:44 pm by Dennis Crouch
Teva Pharmaceuticals USA, Inc., et al. [read post]
6 Nov 2015, 6:58 am
  This is actually presaged in Teva UK Ltd v Merck & Co Inc [2009] EWHC 2952 (Pat), although in that case the issue did not actually arise.Inventive stepThe inventive step argument was essentially – gabapentin is similar to pregabalin, gabapentin is known for the treatment of pain, so it is obvious that pregabalin would also be effective to treat pain. [read post]
21 Oct 2014, 9:03 am by Dennis Crouch
Teva Pharmaceuticals USA, Inc., the Federal Circuit panel affirmed a lower court finding that BMS’s patent covering the Hep-B drug entecavir is invalid as obvious. [read post]
29 Aug 2012, 10:09 pm by FDABlog HPM
  In a December 2011 Complaint, several direct purchasers allege that Wyeth, acting alone and/or in concert with first generic applicant Teva Pharmaceuticals USA, Inc. [read post]
2 Mar 2012, 6:52 am by Bexis
Merck (Vioxx) Trial2006-05-08 Doherty v. [read post]
2 Jun 2011, 12:46 pm by Bexis
Ortho Pharmaceutical Corp., 661 N.E.2d 352, 354 (Ill. 1996); Frye v. [read post]
6 Apr 2011, 12:18 am by Marie Louise
195/09 Synthon BV v Merz Pharma GmbH & Co KG (The SPC Blog) Amrix (Cyclobenzaprine) – US: Eurand files patent infringement complaint against Anchen in response to Para IV certification (Patent Docs) Asacol (Mesalamine) – US: NJ District Court punts in Asacol DJ action to trigger 180-day exclusivity forfeiture; Rules that subsequent ANDA applicant lacks standing: Medeva Pharma Suisse v Par Pharmaceuticals (FDA Law Blog) Cialis (Tadalafil) –… [read post]